Position in ADMA
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$87,928
-$102,880 QoQ
Shares Held
9,759
-6.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MEEDER ASSET MANAGEMENT INC holds $7,091,404 across 37 Biotechnology names. ADMA ranks #5 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,094 | $4,708,465 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,424 | $1,528,950 | |
| 3 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
10,392 | $257,305 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
1,838 | $103,828 | |
| 5 | ADMA |
Adma Biologics, Inc.
This page
|
9,759 | $87,928 | |
| 6 | VCEL |
Vericel Corp
|
1,900 | $61,123 | |
| 7 | MNPR |
Monopar Therapeutics
|
637 | $34,901 | |
| 8 | ENTA |
Enanta Pharmaceuticals Inc
|
2,025 | $25,575 |
All Filings in ADMA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $87,928 | 9,759 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $190,808 | 10,461 | Shares | Sole | 2026-02-11 | |
| 2024-09-30 | $9,075 | 454 | Shares | Sole | 2024-11-07 | |
| 2021-09-30 | $1,137 | 1,008 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $1,612 | 1,008 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $1,771 | 1,008 | Shares | Defined | 2021-04-28 | |
| 2020-03-31 | $6,341 | 2,202 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||